The effect of respiratory and peripheral muscles training on pulmonary and physiological performance in COVID-19 patients

The effect of respiratory and peripheral muscles training on pulmonary and physiological performance in COVID-19 patient

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20230305057618N1

Enrollment

Registered

2023-03-14

Start date

2023-03-19

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19. Coronavirus infection, unspecified

Interventions

Intervention 1: Intervention group 1- Respiratory muscle training: They participate in a six-week training period. In addition to breathing training, these exercises include diaphragmatic breathing ex

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Pneumonia confirmed by Pulmonologist (having signs and radiographic evidence of pneumonia) Stable clinical condition regular participation in the treatment process (before participating in the research) Being interested in participating in training courses

Exclusion criteria

Exclusion criteria: Pulmonary resection Neurological disease Mental illness COPD disease A history of orthopedic and neurological disease that prevents exercise Uncontrolled blood pressure Cardiovascular disease Pregnancy and breastfeeding status

Design outcomes

Primary

Measure	Time frame
Respiratory volumes. Timepoint: Before and after the intervention. Method of measurement: Plethysmography system.;Maximal inspiratory mouth pressures. Timepoint: Before and after the intervention. Method of measurement: Plethysmography system.;Maximal expiratory mouth pressures. Timepoint: Before and after the intervention. Method of measurement: Plethysmography system.;Maximal Voluntary Ventilation. Timepoint: Before and after the intervention. Method of measurement: Plethysmography system.;Diffusing capacity for carbon monoxide. Timepoint: Before and after the intervention. Method of measurement: Plethysmography system.;Ratio diffusing capacity for carbon monoxide to Alveolar Volume (DLCO/VA). Timepoint: Before and after the intervention. Method of measurement: Plethysmography system.	—

Measure

Time frame

Respiratory volumes. Timepoint: Before and after the intervention. Method of measurement: Plethysmography system.;Maximal inspiratory mouth pressures. Timepoint: Before and after the intervention. Method of measurement: Plethysmography system.;Maximal expiratory mouth pressures. Timepoint: Before and after the intervention. Method of measurement: Plethysmography system.;Maximal Voluntary Ventilation. Timepoint: Before and after the intervention. Method of measurement: Plethysmography system.;Diffusing capacity for carbon monoxide. Timepoint: Before and after the intervention. Method of measurement: Plethysmography system.;Ratio diffusing capacity for carbon monoxide to Alveolar Volume (DLCO/VA). Timepoint: Before and after the intervention. Method of measurement: Plethysmography system.

—

Secondary

Measure	Time frame
Red Blood Cell Count or RBC. Timepoint: Before and after the intervention. Method of measurement: CBC blood test.;White Blood Cell Count or WBC. Timepoint: Before and after the intervention. Method of measurement: CBC blood test.;Percentage of red blood cells in a blood or Hematocrit (HCT). Timepoint: Before and after the intervention. Method of measurement: CBC blood test.;White Blood Cell Count or WBC. Timepoint: Before and after the intervention. Method of measurement: CBC blood test.;Count measures the platelet level in blood or Plt. Timepoint: Before and after the intervention. Method of measurement: CBC blood test.	—

Measure

Time frame

Red Blood Cell Count or RBC. Timepoint: Before and after the intervention. Method of measurement: CBC blood test.;White Blood Cell Count or WBC. Timepoint: Before and after the intervention. Method of measurement: CBC blood test.;Percentage of red blood cells in a blood or Hematocrit (HCT). Timepoint: Before and after the intervention. Method of measurement: CBC blood test.;White Blood Cell Count or WBC. Timepoint: Before and after the intervention. Method of measurement: CBC blood test.;Count measures the platelet level in blood or Plt. Timepoint: Before and after the intervention. Method of measurement: CBC blood test.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactVahid Sobhani

Bagheiat-allah University of Medical Sciences

sobhani518@gmail.com+98 21 8755 4391

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026